Quality Indicator for Gastric Cancer Detection Based on Helicobacter pylori Status

Jae Myung Park

doi:10.5946/ce.2020.270

Articles

Page Path: HOME > Clin Endosc > Volume 53(6); 2020 > Article

Commentary Quality Indicator for Gastric Cancer Detection Based on Helicobacter pylori Status: Jae Myung Park^1,2,; Clinical Endoscopy 2020;53(6):629-630.
DOI: https://doi.org/10.5946/ce.2020.270
Published online: November 30, 2020

¹Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

²Catholic Photomedicine Research Institute, The Catholic University of Korea, Seoul, Korea

Correspondence: Jae Myung Park Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-6022, Fax: +82-2-2258-2089, E-mail: parkjerry@catholic.ac.kr

• Received: October 13, 2020 • Revised: November 16, 2020 • Accepted: October 16, 2020

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

3,608 Views
98 Download
3 Web of Science
4 Crossref
3 Scopus

Full Article

Download PDF

NOTES
REFERENCES

See the article "Quality Indicators for the Detection of Helicobacter pylori-Negative Early Gastric Cancer: A Retrospective Observational Study" on page 698.

See “Quality Indicators for the Detection of Helicobacter pylori-Negative Early Gastric Cancer: A Retrospective Observational Study” by Fumiaki Ishibashi, Konomi Kobayashi, Keita Fukushima, et al., on page [Related article:] 698-704.

Esophagogastroduodenoscopy (EGD) has been used to diagnose a wide variety of upper gastrointestinal (GI) disorders, predominantly upper GI cancers. Gastric cancer is the fifth most common malignancy and the third leading cause of cancer-related deaths worldwide [1]. The high mortality rate due to gastric cancer is owing to late diagnosis. Late detection causes a 5-year survival rate of approximately 24%, which can be increased to 40%, with early detection by means of screening [1,2]. The purpose of gastric cancer screening is for early intestinal-type gastric cancer detection; this cancer type comprises more than 95% of all gastric cancers and has sequential stages from atrophy, through dysplasia, to cancer [3].

Gastric cancer screening has been performed in high-incidence regions. Screening using EGD helps in the early detection of gastric cancer, thereby enabling the use of minimally invasive treatment modalities like endoscopic resection. However, quality indicators measuring endoscopy performance should be investigated because of the increasing need for quality control. Few studies have investigated whether the EGD observation time is associated with the neoplasm detection rate [4,5].

Several previous studies reported a positive association between neoplasm detection rates and EGD observation time. A previous prospective study evaluated the association between EGD observation times and the detection rates of atrophic gastritis, intestinal metaplasia, and gastric tumors in 837 symptomatic patients [5] and reported that endoscopists who observed lesions for over 7 minutes without biopsy showed a higher detection rate of high-risk lesions (HRLs) for gastric cancer. However, there were only 11 and 8 patients, respectively, with gastric cancers and gastric adenomas, which limited the accurate interpretation of the results. Furthermore, endoscopy trainees also performed EGD in this study. A Korean study retrospectively analyzed data of more than 100,000 patients who underwent screening EGD [4]. In this study, the observation time was defined as the time to the end of observation after endoscope insertion into the duodenum. Endoscopists who observed lesions for more than 3 minutes without biopsy had a significantly higher neoplasm detection rate than those who observed lesions for less than 3 minutes. Subsequently, all endoscopists were asked to observe lesions for at least 3 minutes as an institutional policy, and the ensuing neoplasm detection rate was prospectively assessed [6]. Consequently, endoscopists showed a significantly higher neoplasm detection rate [6]. These previous studies consistently showed that observation time is a potentially important quality indicator of gastric cancer detection using EGD examination.

In this issue of Clinical Endoscopy, Ishibashi et al. [7] reported the results of a retrospective analysis, i.e., the association between upper GI endoscopy examination time and the detection of HRLs including adenomas, carcinomas, or lymphomas in Japan between April 2017 and March 2019. During this period, 9 physicians performed EGD for 13,477 consecutive asymptomatic individuals. The average observation time for screening Helicobacter pylori (HP)-eradicated and HP-naïve patients was shorter than that for screening HP-positive patients. Multiple regression analyses showed that the observation time was an independent predictor for detecting HRLs in HP-eradicated patients. The authors concluded that observation time and endoscopist experience were quality indicators for detecting HRLs in HP-eradicated and HP-naïve patients, respectively.

Study limitations discussed by the authors were the inaccurate measurement of observation time, younger age of the study population relative to the general Japanese population, and small numbers of HRLs. Moreover, this study also had limitations such as the use of unclear study methods, lack of appropriate statistical analysis, and small number of participating endoscopists. The current study suggests that observation time and endoscopist experience may be determinants of endoscopic quality for EGD.

Conflicts of Interest: The author has no financial conflicts of interest.

REFERENCES

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.Article PubMed
2. Zhang X, Li M, Chen S, et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology 2018;155:347–354.e9.Article PubMed
3. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554–3560.PubMed
4. Park JM, Huo SM, Lee HH, Lee BI, Song HJ, Choi MG. Longer observation time increases proportion of neoplasms detected by esophagogastroduodenoscopy. Gastroenterology 2017;153:460–469.e1.Article PubMed
5. Teh JL, Tan JR, Lau LJ, et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol 2015;13:480–487.e2.Article PubMed
6. Park JM, Kim SY, Shin G, et al. Implementation effect of institutional policy of esophagogastroduodenoscopy observation time on neoplasm detection. Gastrointest Endosc 2020 Sep 8 [Epub]. https://doi.org/10.1016/j.gie.2020.09.002.Article
7. Ishibashi F, Kobayashi K, Fukushima K, et al. Quality indicators for the detection of Helicobacter pylori-negative early gastric cancer: a retrospective observational study. Clin Endosc 2020;53:698–704.Article PubMed PMC PDF

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Cancer Patient Perception Survey to Develop Korean Medicine Clinical Practice Guidelines for Gastric Cancer
Dong Hyeon Kim, Jong Hee Kim, Ji Hye Park, Hwa Seung Yoo, Hyeong Joon Jeon, So Jung Park
Journal of Physiology & Pathology in Korean Medicine.2023; 37(4): 81. CrossRef
Endoscopic diagnosis of early gastric cancer
Dong Chan Joo, Gwang Ha Kim
Journal of the Korean Medical Association.2022; 65(5): 267. CrossRef
[Retracted] Construction of Stomach Cancer Lesion Detection Combined with Drug Therapy Based on Artificial Intelligence
Shengyong Zhai, Lihong Yu, Jing Li, Sandip K. Mishra
Contrast Media & Molecular Imaging.2022;[Epub] CrossRef
Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
Youn I Choi, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Ja Young Seo, Dong Kyun Park
World Journal of Gastroenterology.2021; 27(31): 5247. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Quality Indicator for Gastric Cancer Detection Based on Helicobacter pylori Status

Clin Endosc. 2020;53(6):629-630. Published online November 30, 2020

DOI: https://doi.org/10.5946/ce.2020.270

XML Download

Related articles

Quality Indicator for Gastric Cancer Detection Based on Helicobacter pylori Status